Recombinant Anti-ovarian cancer × Anti-CD3 Bispecific Antibody (CrossMab) has been generated by applying the Crossmab format to generate an IgGshaped entity that binds each ligand with one arm. This BsAb is capable of targeting the tumor, recruits T effector cells via binding to the CD3 esubunit of the T cell receptor complex. It was designed for the treatment of ovarian cancer.
Download resources about recombinant antibody development and antibody engineering to boost your research.
There are currently no Customer reviews or questions for CROSS-L003. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.